IP Library Granted Patent US 9,150,934
Granted Patent B2
US 9,150,934 · App. 14/590,151 · Granted Oct 6, 2015

Methods and compositions for detecting

Inventor: Dennis G. Hooper (Lewisville, TX)
Assignee: Medical Service Consultation International, LLC
C12Q1/6895C12Q2600/112
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,150,934
App. No.
14/590,151
Granted
Oct 6, 2015
Kind
B2
Abstract

The invention relates to a method of identifying an Aspergillus terreus or an Aspergillus niger fungal species in patient tissue or body fluid and to primers and probes for use in such a method.

Claims (14)

1. A method of identifying an Aspergillus niger fungal species in a patient tissue or a patient body fluid, the method comprising the steps of:

extracting and recovering DNA of the Aspergillus niger fungal species from the patient tissue or the patient body fluid;

amplifying the DNA;

hybridizing a probe to the DNA to specifically identify the fungal species, wherein the probe consists of SEQ ID NO: 4; and

specifically identifying the Aspergillus niger fungal species.

2. The method of claim 1 further comprising using a forward primer and a reverse primer to amplify the DNA, wherein the forward primer consists of SEQ ID NO: 5 and the reverse primer consists of SEQ ID NO: 6.

3. The method of claim 1 , wherein the DNA is amplified using PCR.

4. The method of claim 3 , wherein the PCR is real-time PCR.

5. The method of claim 1 , wherein the probe is fluorescently labeled.

6. The method of claim 1 , wherein the probe is bound to a bead dyed with a fluorochrome.

7. The method of claim 1 , wherein the amplified DNA is internal transcribed spacer regions of nuclear ribosomal DNA.

8. The method of claim 1 , wherein the body fluid is selected from the group consisting of urine, nasal secretions, nasal washes, bronchial lavages, bronchial washes, spinal fluid, sputum, gastric secretions, seminal fluid, other reproductive tract secretions, lymph fluid, whole blood, serum, and plasma.

9. The method of claim 1 , wherein the method further comprises the step of administering an anti-fungal agent to the patient.

10. The method of claim 1 , wherein the patient is a transplant patient.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2026
From: MYCODART, INC.
To: REALTIME LABORATORIES, INC.
Reel/Frame 074153/0956 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2018
From: ADVATECT DIAGNOSTICS, LLC
To: REALTIME LABORATORIES, INC.
Reel/Frame 047089/0932 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 8, 2018
From: REALTIME LABORATORIES, INC.
To: MYCODART, INC.
Reel/Frame 047090/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2018
From: HOOPER, DENNIS G.
To: MEDICAL SERVICES CONSULTATION INTERNATIONAL, L.L.C.
Reel/Frame 046934/0954 →
CHANGE OF NAME Recorded Sep 21, 2018
From: MEDICAL SERVICES CONSULTATION INTERNATIONAL, L.L.C.
To: ADVATECT DIAGNOSTICS, LLC
Reel/Frame 047585/0585 →
Continuity (3)
Continuation 13826074 · Mar 14, 2013
Provisional Application 61761619 · Feb 6, 2013
Related Publication 20150125860A1 · May 7, 2015